The period fused rapid modular chemistries with biology-driven discovery, emphasizing constructing diverse small-molecule libraries and linking chemical perturbations to biological readouts. Click chemistry emerged as a practical, high-yield approach to assemble diverse structures in biocompatible settings, while diversity-oriented synthesis expanded exploration of chemical space and informed library design. The integration of phenotypic and transcriptional data enabled mechanism-of-action inference and drug repurposing, and cancer-focused work demonstrated that targeting protein-protein interactions such as MDM2-p53 is a viable therapeutic strategy. Historical Significance: These advances reframed small-molecule discovery as a discipline where modular chemistry, chemical biology, and data-driven analysis co-define the therapeutic landscape; they laid the groundwork for future libraries, screening paradigms, and targeted therapeutics by emphasizing skeletal diversity, modular assembly, and biology-led design.